@article{7862757b08304510b503fb6b95c9eeea,
title = "Biomarkers as intermediate end points in chemoprevention trials",
author = "Lippman, {Scott M.} and Lee, {Jin S.} and Reuben Lotan and Walter Hittelman and Wargovich, {Michael J.} and Hong, {Waun K.}",
note = "Funding Information: Received December 26,1989;revisedFebruary 7,1990; accepted February 13, 1990. Supported in part by Public Health Service grants CA-46303 and CA-18019 from the National Cancer Institute, National Institutes of Health, Department of Health and Human Services. S. M. Lippman is the recipient of an American Cancer Society Clinical Oncology Career Development Award. S. M. Lippman, J. S. Lee, M. J. Wargovich, W. K. Hong (Department of Medical Oncology), R. Lotan (Department of Tumor Biology), W. Hittelman (Department of Cellular Pharmacology), The University of Texas M. D. Anderson Cancer Center, Houston, TX. Correspondence to: Scott M. Lippman, M.D., Department of Medical Oncology, Box 80, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030.",
year = "1990",
month = apr,
day = "4",
doi = "10.1093/jnci/82.7.555",
language = "English (US)",
volume = "82",
pages = "555--560",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "7",
}